Impact of disease modifying therapy on fatigue among multiple sclerosis patients

被引：0
|
作者：
Elkhooly, Mahmoud [1 ,2 ]
Raghib, Muhammad [1 ]
Lazar, Emily [1 ]
Lazar, Adam [1 ]
Liaquat, Zaima [1 ]
Martinez, Carla [1 ]
Rube, Jacob [1 ]
Bernitsas, Evanthia [1 ]
机构：
[1] Wayne State Univ, Neurol, Detroit, MI USA
[2] Minia Univ, Neurol & Psychiat, Al Minya, Egypt
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1620/2035
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [1] Multiple sclerosis, fatigue and disease modifying therapy impact: differences in sleep architecture in patients with multiple sclerosis - Copaxone versus interferons
    Cascone, A.
    Srinivasan, J.
    Giannuzzi, A.
    Wissemann, K.
    Taddeo, M.
    Fafard, L.
    Bumstead, B.
    Zarif, M.
    Buhse, M.
    Gudesblatt, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 324 - 324
  • [2] Impact of Disease-Modifying Therapies on Fatigue in Multiple Sclerosis
    Voelter, H. U.
    Hildebrandt, H.
    Kastrup, A.
    AKTUELLE NEUROLOGIE, 2016, 43 (08) : 511 - 518
  • [3] A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy
    Leist, Thomas P.
    Cole, Michele
    Verma, Sumit
    Keenan, Alex
    Le, Hoa H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [4] Stopping Disease Modifying Therapy in Multiple Sclerosis Patients
    Presas, Silvia
    Vicente Hervas-Garcia, Jose
    Ramo-Tello, Cristina
    NEUROLOGY, 2016, 86
  • [5] Racial impact on use of disease - modifying therapy in multiple sclerosis
    Hyland, M.
    Stone, L. A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S469 - S470
  • [6] Impact of caloric restriction in patients with multiple sclerosis treated with oral disease modifying therapy
    Verdiani, Alice
    Pirronello, Marta
    D'Orso, Silvia
    Corbisiero, Silvia
    Lista, Beatrice
    Perini, Corinna
    Guerrera, Gisella
    Sambucci, Manolo
    Misiti, Andrea
    Buscarinu, Maria Chiara
    Buttari, Fabio
    Ise, Federica
    Micillo, Teresa
    Fusco, Clorinda
    Colamatteo, Alessandra
    Lauritano, Gianluca
    Picozza, Mario
    Carbone, Fortunata
    Quartuccio, Esmeralda
    Matarese, Giuseppe
    Centonze, Diego
    Salvetti, Marco
    Gasperini, Claudio
    Borsellino, Giovanna
    Battistini, Luca
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1521 - 1521
  • [7] Disease modifying therapy use in multiple sclerosis patients with comorbidities
    Conway, D. S.
    Planchon, S. M.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 878
  • [8] Impact of Race on Use of Disease-Modifying Therapy in Multiple Sclerosis
    Hyland, Megan
    Cohen, Jeffrey
    Stone, Lael
    NEUROLOGY, 2013, 80
  • [9] The impact of disease modifying therapy on information processing speed in multiple sclerosis
    Aboseif, A.
    Amin, M.
    Bena, J.
    Macaron, G.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 642 - 643
  • [10] Impact of Disease Modifying Therapy on Quality of Life in Pediatric Multiple Sclerosis
    Doslea, A.
    Parker, M.
    Suslovic, W.
    Ball, L.
    Fleming, M.
    Sady, M.
    Wells, E.
    Khan, I
    ANNALS OF NEUROLOGY, 2019, 86 : S52 - S52
12345